Personalizing Prophylactic Therapy Selection for Adult Patients With Hereditary Angioedema
Personalizing Prophylactic Therapy Selection for Adult Patients With Hereditary Angioedema is organized by Prime Education, LLC.
Release Date: March 17, 2023
Expiration Date: March 16, 2024
Description:
How do prophylactic therapies for hereditary angioedema (HAE) differ in their mechanisms of action, efficacy, safety, routes of administration, and indications?
What factors should you consider when selecting the best treatment for each individual adult patient?
Test your skills in this realistic clinical scenario and see how your choices compare with those of other health care professionals.
Challenge #2 of 2.
This activity is delivered in partnership with the Allergy & Asthma Network.
Agenda:
• Analyzing the Efficacy and Safety Profiles of HAE Prophylactic Therapies
• Integrating Clinical Characteristics Into HAE Treatment Decision-Making
Learning Objectives:
• Differentiate current and emerging treatments based on the latest clinical safety and efficacy data, mechanism of action, indication, and route and frequency of administration
• Develop individualized management plans that integrate patient- and disease-specific factors into personalized treatment decisions
• Apply patient education and shared decision-making to long-term prophylactic treatment discussions for staying attack-free